Milestone Scientific (MLSS) Competitors $0.59 0.00 (-0.34%) As of 09/12/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MLSS vs. MBOT, SGHT, KRMD, AVR, CV, INO, LNSR, LAKE, LUCD, and BSGMShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Microbot Medical (MBOT), Sight Sciences (SGHT), KORU Medical Systems (KRMD), Anteris Technologies Global (AVR), CapsoVision (CV), Inovio Pharmaceuticals (INO), LENSAR (LNSR), Lakeland Industries (LAKE), Lucid Diagnostics (LUCD), and Biosig Technologies (BSGM). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Its Competitors Microbot Medical Sight Sciences KORU Medical Systems Anteris Technologies Global CapsoVision Inovio Pharmaceuticals LENSAR Lakeland Industries Lucid Diagnostics Biosig Technologies Milestone Scientific (NYSE:MLSS) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings. Does the media prefer MLSS or MBOT? In the previous week, Microbot Medical had 9 more articles in the media than Milestone Scientific. MarketBeat recorded 10 mentions for Microbot Medical and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 1.00 beat Microbot Medical's score of 0.79 indicating that Milestone Scientific is being referred to more favorably in the media. Company Overall Sentiment Milestone Scientific Positive Microbot Medical Positive Which has more risk and volatility, MLSS or MBOT? Milestone Scientific has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Do analysts prefer MLSS or MBOT? Milestone Scientific currently has a consensus target price of $1.25, indicating a potential upside of 111.86%. Microbot Medical has a consensus target price of $12.00, indicating a potential upside of 196.30%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than Milestone Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Microbot Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better valuation & earnings, MLSS or MBOT? Milestone Scientific has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$9.08M5.10-$6.93M-$0.09-6.56Microbot MedicalN/AN/A-$11.44M-$0.58-6.98 Is MLSS or MBOT more profitable? Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% Microbot Medical N/A -76.27%-67.54% Do insiders and institutionals have more ownership in MLSS or MBOT? 5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 24.8% of Milestone Scientific shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryMilestone Scientific beats Microbot Medical on 8 of the 14 factors compared between the two stocks. Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$46.35M$26.54M$5.86B$21.59BDividend YieldN/AN/A5.68%3.48%P/E Ratio-8.4313.2275.0629.75Price / Sales5.102.05514.9768.12Price / CashN/A12.8037.5625.00Price / Book5.362.1012.154.58Net Income-$6.93M-$5.31M$3.29B$999.94M7 Day Performance-4.39%-1.46%0.75%0.68%1 Month Performance-1.98%1.06%4.82%3.10%1 Year Performance-37.89%-17.52%60.59%14.39% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific2.7075 of 5 stars$0.59flat$1.25+111.9%-38.2%$46.35M$9.08M-8.4330Positive NewsShort Interest ↓Gap DownMBOTMicrobot Medical2.3517 of 5 stars$4.28-4.8%$9.00+110.1%+322.1%$195.03MN/A-7.3820News CoverageAnalyst ForecastGap UpSGHTSight Sciences3.5808 of 5 stars$3.63-1.8%$4.42+21.8%-48.0%$190.63M$79.87M-3.79210Analyst UpgradeKRMDKORU Medical Systems2.8954 of 5 stars$4.06-0.5%$4.63+13.9%+55.6%$187.73M$33.65M-45.1180Positive NewsAVRAnteris Technologies Global1.7268 of 5 stars$4.68+0.9%$16.50+252.6%N/A$168.77M$2.48M0.00138News CoveragePositive NewsCVCapsoVisionN/A$3.60-1.1%$5.50+52.8%N/A$168.37MN/A0.0090News CoveragePositive NewsGap DownINOInovio Pharmaceuticals3.7437 of 5 stars$2.95+2.9%$8.80+197.9%-64.1%$156.50M$220K-1.13320Positive NewsLNSRLENSAR1.5447 of 5 stars$12.26-0.6%$15.00+22.3%+148.4%$146.52M$53.49M-2.91110News CoveragePositive NewsLAKELakeland Industries4.8405 of 5 stars$14.70-2.0%$26.00+76.9%-27.4%$139.87M$177.65M-4.882,100News CoverageEarnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionLUCDLucid Diagnostics3.1811 of 5 stars$1.24+0.8%$3.65+195.5%+23.3%$133.97M$4.35M-1.0470News CoverageBSGMBiosig Technologies2.2266 of 5 stars$3.92+1.1%$10.00+154.9%+1,316.6%$123.32M$40K0.0050Gap Down Related Companies and Tools Related Companies Microbot Medical Alternatives Sight Sciences Alternatives KORU Medical Systems Alternatives Anteris Technologies Global Alternatives CapsoVision Alternatives Inovio Pharmaceuticals Alternatives LENSAR Alternatives Lakeland Industries Alternatives Lucid Diagnostics Alternatives Biosig Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
